M&T Bank’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,939
| Closed | -$475K | – | 1720 |
|
|
2022
Q3 | $475K | Sell |
1,939
-82
| -4% | -$22.1K | ﹤0.01% | 1108 |
|
|
2022
Q2 | $479K | Buy |
2,021
+174
| +9% | +$47K | ﹤0.01% | 1028 |
|
|
2022
Q1 | $611K | Buy |
1,847
+214
| +13% | +$65.9K | ﹤0.01% | 910 |
|
|
2021
Q4 | $586K | Sell |
1,633
-1
| -0.1% | -$338 | ﹤0.01% | 959 |
|
|
2021
Q3 | $533K | Sell |
1,634
-4
| -0.2% | -$1.35K | ﹤0.01% | 982 |
|
|
2021
Q2 | $512K | Buy |
1,638
+14
| +0.9% | +$4.29K | ﹤0.01% | 1026 |
|
|
2021
Q1 | $519K | Sell |
1,624
-593
| -27% | -$190K | ﹤0.01% | 982 |
|
|
2020
Q4 | $719K | Buy |
2,217
+51
| +2% | +$14.1K | ﹤0.01% | 898 |
|
|
2020
Q3 | $600K | Sell |
2,166
-56
| -3% | -$16.1K | ﹤0.01% | 893 |
|
|
2020
Q2 | $536K | Buy |
2,222
+465
| +26% | +$93.4K | ﹤0.01% | 911 |
|
|
2020
Q1 | $255K | Buy |
1,757
+158
| +10% | +$26.2K | ﹤0.01% | 1215 |
|
|
2019
Q4 | $273K | Sell |
1,599
-207
| -11% | -$38.4K | ﹤0.01% | 1136 |
|
|
2019
Q3 | $321K | Sell |
1,806
-395
| -18% | -$85.4K | ﹤0.01% | 1162 |
|
|
2019
Q2 | $573K | Buy |
2,201
+296
| +16% | +$78.5K | ﹤0.01% | 924 |
|
|
2019
Q1 | $545K | Buy |
1,905
+328
| +21% | +$109K | ﹤0.01% | 917 |
|
|
2018
Q4 | $514K | Buy |
1,577
+20
| +1% | +$6.95K | ﹤0.01% | 899 |
|
|
2018
Q3 | $701K | Buy |
1,557
+278
| +22% | +$110K | ﹤0.01% | 882 |
|
|
2018
Q2 | $523K | Sell |
1,279
-76
| -6% | -$27.5K | ﹤0.01% | 989 |
|
|
2018
Q1 | $394K | Buy |
1,355
+171
| +14% | +$43.3K | ﹤0.01% | 1097 |
|
|
2017
Q4 | $221K | Sell |
1,184
-113
| -9% | -$21.1K | ﹤0.01% | 1389 |
|
|
2017
Q3 | $219K | Buy |
+1,297
| New | +$196K | ﹤0.01% | 1377 |
|
|
2016
Q3 | – | Sell |
-3,445
| Closed | -$377K | – | 1789 |
|
|
2016
Q2 | $377K | Sell |
3,445
-854
| -20% | -$85K | ﹤0.01% | 1145 |
|
|
2016
Q1 | $408K | Buy |
+4,299
| New | +$363K | ﹤0.01% | 1135 |
|
|
2015
Q3 | – | Sell |
-20,615
| Closed | -$1.35M | – | 2064 |
|
|
2015
Q2 | $1.35M | Buy |
20,615
+5,283
| +34% | +$351K | 0.01% | 756 |
|
|
2015
Q1 | $1.1M | Buy |
15,332
+78
| +0.5% | +$4.23K | 0.01% | 827 |
|
|
2014
Q4 | $581K | Sell |
15,254
-5,863
| -28% | -$185K | ﹤0.01% | 1123 |
|
|
2014
Q3 | $524K | Buy |
+21,117
| New | +$535K | ﹤0.01% | 1235 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
M&T Bank's ABMD Position: Q4 2022 in Review
M&T Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,939 shares — an estimated $475K sold.
M&T Bank first reported a position in ABMD in Q3 2014 and held it in 27 quarters. The position peaked at $1.35M in Q2 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- M&T Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- M&T Bank sold 1,939 Abiomed Inc shares in Q4 2022, an estimated $475K.
- M&T Bank first reported a position in Abiomed Inc in Q3 2014 and held it in 27 quarters.
- M&T Bank's Abiomed Inc position peaked at $1.35M in Q2 2015.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on M&T Bank's 13F filing for Q4 2022, filed 13 Feb 2023.